Video

What is the Status of Birth Control Prescribing Among California Pharmacists?

Jon Roth, CEO of the California Pharmacists Association, discusses the status of birth control prescribing among pharmacists in California.

Jon Roth, CEO of the California Pharmacists Association, discusses the status of birth control prescribing among pharmacists in California.

This video was filmed at APhA's 2016 Annual Meeting and Exposition in Baltimore, MD.

Related Videos
Abstract DNA molecule helix inside red blood drop
Woman experiencing pain from UTI -- Image credit: 220 Selfmade studio | stock.adobe.com
Pharmacist helping an older patient -- Image credit: Drazen | stock.adobe.com
Related Content
Eye specialist showing patient a model of the eye -- Image credit: ThawKyar | stock.adobe.com
Published: March 6th 2025 | Updated: March 6th 2025

FDA Approves Revakinagene Taroretcel, Marking First Treatment for MacTel Type 2

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
FDA Approves neffy 1 mg for Type 1 Allergic Reactions, Including Anaphylaxis, in Children
March 6th 2025

FDA Approves neffy 1 mg for Type 1 Allergic Reactions, Including Anaphylaxis, in Children

Aislinn Antrim, Managing Editor
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Nighttime Close-up of Biologic Drug Packaging, Detailed Surface Texture - Image credit: Achiraya | stock.adobe.com
March 5th 2025

Pharmacists Play a Crucial Role in Adalimumab Biosimilars for Patient Care

Kennedy Ferruggia, Assistant Editor
Chronic rhinosinusitis with nasal polyps -- Image credit: Natallia | stock.adobe.com
March 5th 2025

Tezepelumab-Ekko Reduces Nasal Polyp Severity and Need for Surgery in Patients With CRSWNP

Gillian McGovern, Associate Editor